Suppression of CHOP Reduces Neuronal Apoptosis and Rescues Cognitive Impairment Induced by Intermittent Hypoxia by Inhibiting Bax and Bak Activation
Open Access
- 21 August 2021
- journal article
- research article
- Published by Wiley in Neural Plasticity
- Vol. 2021, 1-14
Abstract
Our previous study showed that growth arrest- and DNA damage-inducible gene 153 (GAD153/CHOP) plays an important role in intermittent hypoxia- (IH-) induced apoptosis and impaired synaptic plasticity. This study is aimed at determining which signaling pathway is activated to induce CHOP and the role of this protein in mitochondria-dependent apoptosis induced by IH. In the in vivo study, mice were placed in IH chambers for 8h daily over a period of 2 weeks; the IH chambers had oxygen (O2) concentrations that oscillated between 10 and 21, cycling every 90s. In the in vitro study, PC12 cells were exposed to 21 O2 (normoxia) or 8 IH cycles (25min at 21 O2 and 35min at 0.1 O2 for each cycle). After 2 weeks of IH treatment, we observed that the expression levels of phosphorylated protein kinase-like endoplasmic reticulum kinase (p-PERK), activating transcription factor 4 (ATF-4) and phosphorylated eukaryotic initiation factor 2 alpha (p-elf2α), were increased, but the levels of activating transcription factor 6 (ATF-6) and inositol-requiring enzyme 1 (IRE-1) were not increased. GSK2606414, a specific chemical inhibitor of the PERK pathway, reduced the expression of p-PERK, ATF-4, p-elf2α, and CHOP and rescued ER structure. In addition, Bax and Bak accumulated in the mitochondria after IH treatment, which induced cytochrome c release and initiated apoptosis. These effects were prevented by GSK2606414 and CHOP shRNA. Finally, the impaired long-term potentiation and long-term spatial memory in the IH group were rescued by GSK2606414. Together, the data from the in vitro and in vivo experiments indicate that IH-induced apoptosis and impaired synaptic plasticity were mediated by the PERK-ATF-4-CHOP pathway. Suppressing PERK-ATF-4-CHOP signaling pathway attenuated mitochondria-dependent apoptosis by reducing the expression of Bax and Bak in mitochondria, which may serve as novel adjunct therapeutic strategy for ameliorating obstructive sleep apnea- (OSA-) induced neurocognitive impairment.Keywords
Funding Information
- Science and Technology Innovation Project for College Students in Zhejiang Province (2020R425006, LQ18H020007, LY19H280008, LY19H010002)
- Natural Science Foundation of Zhejiang Province (2020R425006, LQ18H020007, LY19H280008, LY19H010002)
This publication has 31 references indexed in Scilit:
- C/EBP Homologous Binding Protein (CHOP) Underlies Neural Injury in Sleep Apnea ModelSLEEP, 2013
- Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippocampal long-term synaptic plasticityNeurobiology of Disease, 2010
- Mitochondria and cell death: outer membrane permeabilization and beyondNature Reviews Molecular Cell Biology, 2010
- Huperzine A protects isolated rat brain mitochondria against β-amyloid peptideFree Radical Biology and Medicine, 2009
- Isolation of mitochondria from rat brain using Percoll density gradient centrifugationNature Protocols, 2008
- IRE1 Signaling Affects Cell Fate During the Unfolded Protein ResponseScience, 2007
- ER Stress Triggers Apoptosis by Activating BH3-Only Protein BimCell, 2007
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006
- NF-κB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxietyBehavioural Brain Research, 2004
- XBP-1 Regulates a Subset of Endoplasmic Reticulum Resident Chaperone Genes in the Unfolded Protein ResponseMolecular and Cellular Biology, 2003